Commentary: Moving Toward Clear, Evidence-based, and Effective State Policies for Addiction Medicine.
J Addict Med
; 16(2): 130-131, 2022.
Article
in English
| MEDLINE | ID: covidwho-1816281
ABSTRACT
State policies play a critical role in determining health care delivery, health equity, and health outcomes, but vary widely in scope, target, restrictiveness, and goals. Understanding how such policies impact health care is critical to development of evidence-based policies, but difficult in the absence of organized and standardized approaches to analysis. Development of themes and frameworks for analysis, and identification of policies supported by evidence, are important steps in moving toward more rational and aligned policies. Buprenorphine treatment for opioid use disorder provides a good example and methodological foundation. At the same time, state policies are promulgated within a larger policy, treatment, and socio-economic environment, and these influences must be considered as well.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Buprenorphine
/
Addiction Medicine
/
Opioid-Related Disorders
Type of study:
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Addict Med
Year:
2022
Document Type:
Article
Affiliation country:
ADM.0000000000000862
Similar
MEDLINE
...
LILACS
LIS